The 1st Asia Pacific Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Shanghai, China, June 2-5, 2011 |
|
| |
| Industry Advisory Board (IAB) |
 |
|
|
We view industry not only as a sponsor of our academic activity but rather as partners that can promote new research and innovative developments that will undoubtedly originate from this challenging meeting of interdisciplinary experts of the highest quality.
| S. Basavappa, Takeda |
|
| R. Chaiken, Pfizer |
|
| J. Chan, Eli Lilly |
|
| G. Giazzon, Takeda |
|
| H. Gringolts, Johnson & Johnson |
|
| A. Grooten, Boehringer Ingelheim |
|
| B. Hirshberg, Astra Zeneca |
|
| H. Katzeff, Merck |
|
| L. Lee, Janssen Cilag |
|
| S. Nagendran, Daichii Sankyo |
|
| C. Rondinone, Roche |
|
| M. Von Eynatten, Boehringer Ingelheim |
|
| A. Xu, Eli Lilly |
|
| T. Yu, Novo Nordisk |
|
| K. Zhang, Novo Nordisk |
|
|
|
WebStudio.co.il